Nicorette Lozenge 2 mg
Texto original en francés.
Producto de salud natural autorizado en Canadá
- Titular
- Kenvue Canada Inc.
- NPN o DIN-HM
- 80069404
- Estado
- Licencia activa
- Fecha de licencia
- 13 de mayo de 2016
- Fecha de revisión
- 29 de julio de 2024
- Forma
- Pastille
- Vía de administración
- Buccale
- Tipo de solicitud
- Non traditionnelle
El análisis de dosis orales no se aplica sin una vía exclusivamente oral establecida.
Composición
| Ingrediente medicinal y fuente | Por unidad posológica, según la fuente |
|---|---|
| 3-((2S)-1-méthyl-2-pyrrolidinyl)-pyridine Fuente : Nicotine polacrilex | 2 milligramme |
Ingredientes no medicinales
Carbonate de sodium anhydre, Bicarbonate de potassium, Menthol, D-Mannitol, Saveur de menthe poivrée, Alginate de sodium, Acésulfame potassium, Stéarate de magnésium, Gomme de xanthane, Eau purifiée, Poly(carbophile) de calcium, Saveur, Saveur de cerise
Dosis recomendadas en Canadá
| Población | Edad | Cantidad por toma | Frecuencia |
|---|---|---|---|
| Adultes | minimum : 19 ans | 1 Pastille | maximum : 15 Tous les jours |
Usos autorizados en Canadá
NICORETTE(R) Lozenge is a medicine that can help you stop smoking by reducing withdrawal symptoms and nicotine cravings. NICORETTE(R) Lozenge is a form of Nicotine Replacement Therapy (NRT) that can help double your chances of quitting successfully. NICORETTE(R) Lozenge provides a lower level of nicotine to your blood than cigarettes and allows you to slowly decrease your body's need for nicotine. It works as a temporary aid to help you quit smoking by reducing nicotine withdrawal symptoms such as irritability, frustration, anxiety, difficulty in concentration and restlessness. Without these powerful urges for the cigarettes you "need", getting rid of the "habit" cigarettes becomes much easier. The good news is that NICORETTE(R) Lozenge contains no tar or carbon monoxide, and therefore doesn't present the same medical risks as cigarettes. NICORETTE(R) Lozenge can be used to quit immediately or to quit gradually by reducing the number of cigarettes you smoke each day before making a quit attempt. Although smoking cessation is preferable, it can also be used in cases in which you temporarily refrain from smoking, for example, in smoke-free areas or in other situations when you wish to avoid smoking.
Texto original en inglés.
Un uso autorizado en Canadá no es una declaración de propiedades saludables autorizada en la Unión Europea. Consulte el registro de declaraciones de propiedades saludables.
Advertencias en Canadá
Précautions et mises en garde : Ask a doctor before use if you have/have had heart, thyroid, circulation, stomach problems, high blood pressure, or if you are taking insulin or any prescription medicine. If you have diabetes, you may need to monitor your blood sugar levels more closely than normal when you stop smoking and start using this product. Keep out of reach of children and pets.
Texto original en francés.
Effets indésirables connus : For some people, the nicotine in NICORETTE® Mini Lozenge can occasionally cause mouth or throat irritation but most people get used to this with ongoing use. It can also cause headaches, nausea, hiccups, upset stomach or dizziness. Most of these side effects occur when you first start taking the product and depend on how much you are using. If you have used too many lozenges, you may develop symptoms of overdose such as nausea/upset stomach, drooling headache, abdominal pain, vomiting, diarrhea, cold sweat, dizziness, disturbed hearing and vision, mental confusion, marked weakness, fainting, rapid heartbeat or difficulty breathing. At high doses, these symptoms may be followed by low blood pressure, weak and irregular pulse, breathing difficulties, extreme exhaustion, circulatory collapse and general convulsions.
Texto original en francés.
Contre-indications : Do not use if you are under 18 years of age, are pregnant or breastfeeding, are an occasional or non-smoker or are allergic to nicotine or to any of the non-medicinal ingredients in the product.
Texto original en francés.
Fuente
Ficha oficial de Health Canada, licencia 80069404
Base de datos de productos de salud natural autorizados (BDPSNH), Health Canada: productos autorizados, ingredientes, dosis, usos y advertencias, consultado el 27 de octubre de 2026.
Contient des informations visées par la Licence du gouvernement ouvert – Canada (Santé Canada, BDPSNH)
Texto original en francés.
Texto original en francés.
La fórmula vendida en Europa con el mismo nombre puede ser diferente. Esta información no sustituye el consejo de un médico o farmacéutico.
Lista en la revisión oficial del (registro: Base de datos de productos de salud natural autorizados (BDPSNH), Health Canada: productos autorizados, ingredientes, dosis, usos y advertencias).